344 studies found for:    NIAID | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
21 Recruiting Assessment of Alterations in Immune Function During Pregnancy and Post Parturition
Conditions: Pregnancy;   Immune Function
Intervention:
22 Recruiting Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
Condition: Normal Volunteer
Intervention:
23 Not yet recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
24 Not yet recruiting A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDY
Conditions: HIV;   AIDS;   Epidemiology;   Prevention
Intervention:
25 Not yet recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
26 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
27 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
28 Not yet recruiting SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Conditions: Leishmaniasis;   Effects of Immunotherapy
Interventions: Drug: SCH708980 Anti-IL-10 monoclonal;   Drug: AmBisome
29 Recruiting LCI Apheresis to Obtain Plasma or White Blood Cells
Condition: Apheresis
Intervention:
30 Not yet recruiting Apheresis to Obtain Plasma and White Blood Cells in Malies
Condition: Malaria
Intervention:
31 Recruiting Normal Immunological Parameters Among Healthy Volunteers in Kambila, Mali
Condition: Malaria
Intervention:
32 Recruiting Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia
Condition: Malaria
Intervention:
33 Recruiting Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Imatinib Mesylate
34 Recruiting Treatment of Patients With Cysticercosis With Praziquantel or Albendazole
Condition: Cysticercosis
Intervention:
35 Recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine
36 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
37 Recruiting Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Conditions: Chronic Granulomatous Disease (CGD);   Atherosclerosis;   Immune Deficiencies;   Inflammatory Bowel Disease
Intervention:
38 Recruiting Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
Condition: Anthrax
Intervention:
39 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
40 Recruiting Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Conditions: Hyper-IgM Syndrome;   Ectodermal Dysplasia
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years